Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021
Operating activities
Net income	$ 1,062	$ 1,061
Adjustments to reconcile net income to operating cash flows:
Depreciation and amortization	351	346
Postretirement benefit plan expense (benefit)	(189)	(112)
Deferred income taxes	26	4
Stock compensation	56	50
Other	(16)	(29)
Postretirement benefit plan contributions	(17)	(15)
Changes in operating assets and liabilities, net of acquisitions:
Trade receivables	(526)	(196)
Inventories	(343)	(103)
Accounts payable	501	198
All other current assets and liabilities	275	(59)
Net cash provided by (used in) operating activities	1,180	1,145
Investing activities
Additions to properties	(350)	(408)
Issuance of notes receivable	0	(29)
Repayments of notes receivable	10	28
Investments in unconsolidated entities	0	(10)
Purchases of available for sale securities	(15)	(56)
Sales of available for sale securities	14	69
Settlement of net investment hedges	37	10
Collateral paid on derivatives	(10)	(9)
Other	2	20
Net cash provided by (used in) investing activities	(312)	(385)
Financing activities
Net issuances (reductions) of notes payable	37	343
Issuances of long-term debt	0	361
Reductions of long-term debt	(33)	(646)
Net issuances of common stock	244	50
Common stock repurchases	(300)	(240)
Cash dividends	(596)	(590)
Other	(17)	(18)
Net cash provided by (used in) financing activities	(665)	(740)
Effect of exchange rate changes on cash and cash equivalents	(116)	(15)
Increase (decrease) in cash and cash equivalents	87	5
Cash and cash equivalents at beginning of period	286	435
Cash and cash equivalents at end of period	373	440
Supplemental cash flow disclosures of non-cash investing activities
Additions to properties included in accounts payable	$ 75	$ 91